Pirazolil - 1 - 3 - (4 - ((2 - anilinopirimidin - 4-yl) oxy) naftalen - 1 - il) ureas as p38 MAP Kinase Inhibitors

摘要

There is provided a compound of formula (I) which is an inhibitor of the family of p38 mitogen-activated protein kinase enzymes, and to its use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and COPD.